On the contrary, in KRASwt/LKB1wt cells or in the KRASmut/LKB1wt experimental tumors, metformin determined activation of the LKB1/AMPK signaling pathway, thus reducing cell proliferation and metabolic requirements and preventing metabolic crisis in cancer cells. Here, STK11 is linked to cancer.